These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1833454)

  • 21. Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1.
    Facchinetti V; Lopa R; Spreafico F; Bolognese F; Mantovani R; Tavner F; Watson R; Introna M; Golay J
    Oncogene; 2000 Aug; 19(34):3931-40. PubMed ID: 10951586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the promoter region of the c-yes proto-oncogene: the importance of the GC boxes on its promoter activity.
    Matsuzawa Y; Semba K; Kawamura-Tsuzuku J; Sudo T; Ishii S; Toyoshima K; Yamamoto T
    Oncogene; 1991 Sep; 6(9):1561-7. PubMed ID: 1923523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1.
    Kurtz CB; O'Toole E; Christensen SM; Weis JH
    J Immunol; 1990 May; 144(9):3581-91. PubMed ID: 2139460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a second flagellin gene and functional characterization of a sigma70-like promoter upstream of a Leptospira borgpetersenii flaB gene.
    Lin M; Dan H; Li Y
    Curr Microbiol; 2004 Feb; 48(2):145-52. PubMed ID: 15057484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of complement C3 receptors on human astrocytes.
    Gasque P; Chan P; Mauger C; Schouft MT; Singhrao S; Dierich MP; Morgan BP; Fontaine M
    J Immunol; 1996 Mar; 156(6):2247-55. PubMed ID: 8690915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular interaction of EBV/C3d receptor (CR2) with p68, a calcium-binding protein present in normal but not in transformed B lymphocytes.
    Barel M; Gauffre A; Lyamani F; Fiandino A; Hermann J; Frade R
    J Immunol; 1991 Aug; 147(4):1286-91. PubMed ID: 1831222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor.
    Fujisaku A; Harley JB; Frank MB; Gruner BA; Frazier B; Holers VM
    J Biol Chem; 1989 Feb; 264(4):2118-25. PubMed ID: 2563370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells.
    Taylor RL; Cruickshank MN; Karimi M; Ng HL; Quail E; Kaufman KM; Harley JB; Abraham LJ; Tsao BP; Boackle SA; Ulgiati D
    Cell Mol Immunol; 2016 Jan; 13(1):119-31. PubMed ID: 25640655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine complement receptor gene expression: Cr2 gene transcripts are depressed during a high dose microbial challenge.
    Tan SS; O'Toole EM; Kurtz CB; Weis JH
    Immunology; 1993 May; 79(1):82-8. PubMed ID: 8509145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of tandem E-box motifs within human Complement receptor 2 (CR2/CD21) promoter reveals cell specific roles for RP58, E2A, USF and localized chromatin accessibility.
    Cruickshank MN; Dods J; Taylor RL; Karimi M; Fenwick EJ; Quail EA; Rea AJ; Holers VM; Abraham LJ; Ulgiati D
    Int J Biochem Cell Biol; 2015 Jul; 64():107-19. PubMed ID: 25817480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of the human complement receptor 2 (CR2/CD21) promoter: characterization of basal transcriptional mechanisms.
    Ulgiati D; Pham C; Holers VM
    J Immunol; 2002 Jun; 168(12):6279-85. PubMed ID: 12055242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Notch signaling induces a transcriptionally permissive state at the Complement C3d Receptor 2 (CR2) promoter in a pre-B cell model.
    Ng HL; Taylor RL; Cheng J; Abraham LJ; Quail E; Cruickshank MN; Ulgiati D
    Mol Immunol; 2020 Dec; 128():150-164. PubMed ID: 33129017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes.
    Moore MD; Cooper NR; Tack BF; Nemerow GR
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9194-8. PubMed ID: 2827171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of putative intronic control sequences does not alter cell or stage specific expression of Cr2.
    Roundy KM; Weis JJ; Weis JH
    Mol Immunol; 2009 Dec; 47(2-3):517-25. PubMed ID: 19740539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of murine complement receptor type 2.
    Fingeroth JD; Benedict MA; Levy DN; Strominger JL
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):242-6. PubMed ID: 2783485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CR2/CD21 proximal promoter activity is critically dependent on a cell type-specific repressor.
    Ulgiati D; Holers VM
    J Immunol; 2001 Dec; 167(12):6912-9. PubMed ID: 11739509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Characterization of chCR2, a Protein That Binds Chicken Complement Component 3d.
    Jin H; Kong Z; Jiang B; Tu M; Xu J; Cheng J; Liu W; Zhang Z; Li Y
    J Immunol; 2023 May; 210(9):1408-1418. PubMed ID: 36971659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 16 amino acid synthetic peptide derived from human C3d triggers proliferation and specific tyrosine phosphorylation of transformed CR2-positive human lymphocytes and of normal resting B lymphocytes.
    Frade R; Hermann J; Barel M
    Biochem Biophys Res Commun; 1992 Oct; 188(2):833-42. PubMed ID: 1445326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and function of the B-lymphocyte Epstein-Barr virus/C3d receptor.
    Nemerow GR; Moore MD; Cooper NR
    Adv Cancer Res; 1990; 54():273-300. PubMed ID: 2136962
    [No Abstract]   [Full Text] [Related]  

  • 40. A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation.
    Makar KW; Ulgiati D; Hagman J; Holers VM
    Int Immunol; 2001 May; 13(5):657-64. PubMed ID: 11312253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.